Kewaunee Scientific Corporation (KEQU)
NASDAQ: KEQU · Real-Time Price · USD
36.01
-0.33 (-0.91%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Kewaunee Scientific Balance Sheet
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Cash & Equivalents | 9.95 | 14.94 | 23.27 | 8.08 | 4.43 |
Cash & Short-Term Investments | 9.95 | 14.94 | 23.27 | 8.08 | 4.43 |
Cash Growth | -33.41% | -35.78% | 188.03% | 82.22% | -14.85% |
Accounts Receivable | 58.74 | 62.38 | 45.06 | 46.08 | 41.25 |
Other Receivables | - | - | - | - | 13.46 |
Total Trade Receivables | 58.74 | 62.38 | 45.06 | 46.08 | 54.71 |
Inventory | 30.53 | 32.85 | 20.68 | 21.89 | 23.8 |
Other Current Assets | 6.18 | 8.19 | 7.81 | 11.87 | 8.63 |
Total Current Assets | 105.4 | 118.36 | 96.82 | 87.92 | 91.57 |
Net Property, Plant & Equipment | 33.16 | 36.14 | 25.1 | 25.57 | 22.69 |
Other Intangible Assets | 16.29 | 17.83 | - | - | - |
Goodwill | 12.49 | 12.49 | - | - | - |
Other Long-Term Assets | 10.98 | 9.83 | 12.85 | 5.41 | 4.51 |
Total Assets | 178.31 | 194.65 | 134.77 | 118.9 | 118.77 |
Accounts Payable | 22.46 | 27.03 | 23.26 | 23.6 | 27.32 |
Accrued Expenses | 12.07 | 12.56 | 7.1 | 6.08 | 7.84 |
Short-Term Debt | 0.07 | 0.99 | 3.1 | 3.59 | 1.59 |
Current Portion of Long-Term Debt | 5.76 | 3.69 | 0.71 | 0.64 | 0.58 |
Current Portion of Leases | 3.85 | 3.37 | 2.23 | 2.05 | 1.45 |
Unearned Revenue | 4.15 | 6.07 | 4.37 | 4.1 | 3.53 |
Total Current Liabilities | 48.35 | 53.71 | 40.78 | 40.05 | 42.29 |
Long-Term Debt | 40.57 | 60.58 | 27.42 | 28.13 | 28.78 |
Long-Term Leases | 6.57 | 8.95 | 5.67 | 7.28 | 6.41 |
Other Long-Term Liabilities | 6.01 | 5.17 | 4.69 | 4.94 | 5.12 |
Total Long-Term Liabilities | 53.15 | 74.7 | 37.78 | 40.36 | 40.3 |
Total Liabilities | 101.5 | 128.41 | 78.56 | 80.41 | 82.59 |
Common Stock | 7.42 | 7.35 | 7.27 | 7.08 | 6.98 |
Treasury Stock | -3.65 | -3.65 | -2.05 | -0.05 | -0.05 |
Additional Paid-in Capital | 7.02 | 5.64 | 5.41 | 5.06 | 4.48 |
Accumulated Other Comprehensive Income | -4.61 | -3.8 | -3.38 | -3.44 | -3.74 |
Retained Earnings | 68.54 | 58.92 | 47.51 | 28.76 | 28.02 |
Total Common Shareholders' Equity | 74.72 | 64.46 | 54.76 | 37.41 | 35.69 |
Minority Interest | 2.09 | 1.79 | 1.45 | 1.08 | 0.49 |
Shareholders' Equity | 74.72 | 64.46 | 56.21 | 38.49 | 36.18 |
Total Liabilities & Equity | 178.31 | 194.65 | 134.77 | 118.9 | 118.77 |
Total Debt | 56.82 | 77.58 | 39.14 | 41.7 | 38.79 |
Net Cash (Debt) | -46.87 | -62.63 | -15.87 | -33.62 | -34.36 |
Net Cash Per Share | -15.71 | -21.02 | -5.40 | -11.59 | -12.33 |
Book Value | 74.72 | 64.46 | 54.76 | 37.41 | 35.69 |
Book Value Per Share | 25.05 | 21.64 | 18.64 | 12.89 | 12.81 |
Tangible Book Value | 45.94 | 34.14 | 54.76 | 37.41 | 35.69 |
Tangible Book Value Per Share | 15.40 | 11.46 | 18.64 | 12.89 | 12.81 |